| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
BRCA genes: lessons learned from experimental and clinical cancer
|
Muggia, F.
|
|
|
22 |
S1 |
p. i7-i10
|
article
|
| 2 |
Conclusions: fruits of the convergence of laboratory, clinic and public
|
Muggia, F.
|
|
|
22 |
S1 |
p. i67-i68
|
article
|
| 3 |
Editorial Board
|
|
|
|
22 |
S1 |
p. iii
|
article
|
| 4 |
Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers
|
Milne, R.L.
|
|
|
22 |
S1 |
p. i11-i17
|
article
|
| 5 |
Hereditary breast cancer: clinical features and risk reduction strategies
|
Paradiso, A.
|
|
|
22 |
S1 |
p. i31-i36
|
article
|
| 6 |
Impact of MRI surveillance and breast cancer detection in young women with BRCA mutations
|
Warner, E.
|
|
|
22 |
S1 |
p. i44-i49
|
article
|
| 7 |
Innovative technology for cancer risk analysis
|
Tommas, S.
|
|
|
22 |
S1 |
p. i37-i43
|
article
|
| 8 |
Introduction
|
Paradiso, A.
|
|
|
22 |
S1 |
p. i5-i6
|
article
|
| 9 |
Old and new concepts in histopathological characterization of familial breast cancer
|
Mangia, A.
|
|
|
22 |
S1 |
p. i24-i30
|
article
|
| 10 |
Prevention of breast cancer: the case for studying inhibition of IGF-1 actions
|
Smith, J.
|
|
|
22 |
S1 |
p. i50-i52
|
article
|
| 11 |
Social and ethical implications of BRCA testing
|
Surbone, A.
|
|
|
22 |
S1 |
p. i60-i66
|
article
|
| 12 |
Table of Contents
|
|
|
|
22 |
S1 |
p. iv
|
article
|
| 13 |
The clinical development of inhibitors of poly(ADP-ribose) polymerase
|
Calvert, H.
|
|
|
22 |
S1 |
p. i53-i59
|
article
|
| 14 |
Title Page
|
|
|
|
22 |
S1 |
p. ii
|
article
|
| 15 |
Unclassified variants in BRCA genes: guidelines for interpretation
|
Radice, P.
|
|
|
22 |
S1 |
p. i18-i23
|
article
|
Journal description